NEW YORK – What were the articles that gained the most interest from GenomeWeb readers last week? Here are the top five:
- Illumina Wins Patent Office Action, Invalidating Columbia University Patent on NGS
- Columbia University, Qiagen Hit Back at Illumina in NGS Patent Fight With New Suit
- 10x Genomics Prices IPO at $39 Per Share
- Thermo Fisher Scientific, Eli Lilly to Develop CDx for RET Inhibitor
- Exact Sciences Stock Falls on Publication of New CRC Screening Cost-Effectiveness Study